Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

… Rachael Wood, Ph.D. … Shah ASV, Wood R, Gribben C, et al. Risk of hospital admission
with coronavirus disease 2019 in healthcare workers and their households: nationwide …

Objective To assess the risk of hospital admission for coronavirus disease 2019 (covid-19)
among patient facing and non-patient facing healthcare workers and their household …

Background The UK COVID-19 vaccination programme has prioritised vaccination of those
at the highest risk of COVID-19 mortality and hospitalisation. The programme was rolled out …

Small newborns are vulnerable to mortality and lifelong loss of human capital. Measures of
vulnerability previously focused on liveborn low-birthweight (LBW) babies, yet LBW reduction …

Preterm birth (PTB) is the leading cause of infant mortality worldwide. Changes in PTB rates,
ranging from −90% to +30%, were reported in many countries following early COVID-19 …

Background: The BNT162b2 mRNA (Pfizer-BioNTech) and ChAdOx1 (Oxford-AstraZeneca)
COVID-19 vaccines have demonstrated high efficacy against infection in phase 3 clinical …

STUDY QUESTION What is the impact of cancer in females aged ≤39 years on subsequent
chance of pregnancy? SUMMARY ANSWER Cancer survivors achieved fewer pregnancies …